Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma
Bacterial antitumor therapy has great application potential given its unique characteristics, including genetic manipulation, tumor targeting specificity and immune system modulation. However, the nonnegligible side effects and limited efficacy of clinical treatment limit their biomedical applicatio...
Saved in:
Main Authors: | Leyang Wu (Author), Lin Li (Author), Shufeng Li (Author), Lina Liu (Author), Wenjie Xin (Author), Chenyang Li (Author), Xingpeng Yin (Author), Xuebo Xu (Author), Feifei Bao (Author), Zichun Hua (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Culture of attenuated Salmonella Typhimurium VNP20009 in animal-product-free media does not alter schwannoma growth control
by: Sherif G. Ahmed, et al.
Published: (2023) -
Anti-Tumor Effects of Engineered VNP20009-Abvec-Igκ-mPD-1 Strain in Melanoma Mice via Combining the Oncolytic Therapy and Immunotherapy
by: De-Xi Zhou, et al.
Published: (2022) -
Infant bacteremia due to Salmonella typhimurium
by: Hena Rani, et al.
Published: (2011) -
Salmonella typhimurium targeting with monoclonal antibodies prevents infection in mice.
by: Jie Li, et al.
Published: (2023) -
THE DYNAMICS OF ANTIMICROBIAL RESISTANCE OF Salmonella typhimurium ISOLATES.
by: Erleta Peqini, et al.
Published: (2011)